Johanna focuses on developing scientifically sound translation of customer and market needs to R&D strategy and projects, being the key Clinical Sciences link to customers and external scientific communities. Previously she led GHNS group, which conducted and coordinated in vitro, pre-clinical and clinical studies on IFF’s ingredients. She has extensive R&D experience in understanding the gut microbiota and its impact on health, especially on the influence of probiotics, nutrition and fibres.